FindTrial
Sign In

Risk factors and prevention of associated with postoperative pain in hydroxyapatite orbital implantation under general anesthesia

Risk factors and prevention of associated with postoperative pain in hydroxyapatite orbital implantation under general anesthesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018843
Enrollment
Unknown
Registered
2018-10-13
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperation pain

Interventions

Group 1:flurbiprofen axetil
Group 2:nalbuphine
Group 3:flurbiprofen axetil combined with nalbuphine

Sponsors

Zhongshan Ophthalmic Center, Sun Yat-sun University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 16-65 years old; 2. patients receiving hydroxyapatite orbital implantation under general anesthesia (including one-stage and two-stage surgery).

Exclusion criteria

Exclusion criteria: 1. inability to communicate (including impairment of sensorium); 2. inability to provide informed consent; 3. with mental illness; 4. any other reasons are not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
Self-rating Anxiety Scale;discomfort;postoperative pain;—

Secondary

MeasureTime frame
demographic profiles;medical history of participants;general information;postoperative adverse reactions;Operative implantation body;hemostatic material;Postoperative conjunctival sac situation;—

Countries

China

Contacts

Public ContactWenjun Guo

Zhongshan Ophthalmic Center, Sun Yat-sun University

wenjun-guo@qq.com+86 20 8733 1548

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026